FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for TIVICAY (dolutegravir) from ViiV Healthcare Company, resulting in updated labeling per the supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

SUPPL AP for TIVICAY (DOLUTEGRAVIR SODIUM)